يعرض 1 - 10 نتائج من 45 نتيجة بحث عن '"Zika"', وقت الاستعلام: 1.61s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: Lausanne University Hospital, Centre Hospitalier de l'Ouest Guyanais Franck Joly [Saint-Laurent-du-Maroni, Guyane Française], Environnement et Risques infectieux - Environment and Infectious Risks (ERI), Institut Pasteur [Paris] (IP), Institut Pasteur de la Guyane, Réseau International des Instituts Pasteur (RIIP), University of Bern, Institut Pasteur [Paris]

    المصدر: Emerging Infectious Diseases, Vol 27, Iss 2, Pp 490-498 (2021)
    Emerging Infectious Diseases
    Emerging Infectious Diseases, 2021, 27 (2), pp.490-498. ⟨10.3201/eid2702.200684⟩
    Pomar, Léo; Lambert, Véronique; Matheus, Séverine; Pomar, Céline; Hcini, Najeh; Carles, Gabriel; Rousset, Dominique; Vouga, Manon; Panchaud Monnat, Alice; Baud, David (2021). Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes. Emerging infectious diseases, 27(2), pp. 490-498. U.S. National Center for Infectious Diseases 10.3201/eid2702.200684 <http://dx.doi.org/10.3201/eid2702.200684>
    Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2021, 27 (2), pp.490-498. ⟨10.3201/eid2702.200684⟩

    وصف الملف: application/pdf

  4. 4
  5. 5

    المساهمون: Unité des Virus Emergents (UVE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Malaria Research and Training Center [Bamako, Mali], Université de Bamako, Ministère de la Santé et des Affaires Sociales du Mali [Bamako, Mali], Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Etablissement Français du Sang - Alpes-Méditerranée (EFS - Alpes-Méditerranée), Etablissement Français du Sang, German Center for Infection Research, Partnersite Munich (DZIF), Arbovirus et Insectes Vecteurs - Arboviruses and Insect Vectors, Institut Pasteur [Paris] (IP), Modélisation mathématique des maladies infectieuses - Mathematical modelling of Infectious Diseases, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), ANR-16-CONV-0005,INCEPTION,Institut Convergences pour l'étude de l'Emergence des Pathologies au Travers des Individus et des populatiONs(2016), BUISINE, Soline, Aix Marseille Université (AMU)-Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université des sciences, des techniques et des technologies de Bamako (USTTB), Institut Pasteur [Paris], Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Emerging Infectious Diseases
    Emerging Infectious Diseases, 2020, 26 (5), pp.945-952. ⟨10.3201/eid2605.191383⟩
    Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2020, 26 (5), pp.945-952. ⟨10.3201/eid2605.191383⟩
    Emerging Infectious Diseases, Vol 26, Iss 5, Pp 945-952 (2020)

  6. 6
  7. 7

    المصدر: Emerging Infectious Diseases, Vol 25, Iss 8, Pp 1452-1460 (2019)
    Emerging Infectious Diseases

  8. 8
  9. 9

    المساهمون: Fiji Centre for Communicable Disease Control [Suva, Fidji], University of the South Pacific (USP), Institut Louis Malardé [Papeete] (ILM), Institut de Recherche pour le Développement (IRD), Fiji National University, Institut Pasteur [Paris] (IP), London School of Hygiene and Tropical Medicine (LSHTM), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Brigham & Women’s Hospital [Boston] (BWH), Harvard Medical School [Boston] (HMS), Harvard Humanitarian Initiative [Cambridge, Massachusetts], Queensland University of Technology [Brisbane] (QUT), Australian National University (ANU), Aix Marseille Université (AMU), This work was part of ISID-Pacific and R-ZERO Pacific programs funded by the French Ministry for Europe and Foreign Affairs (Pacific Fund nos. 06314-09/04/14, 12115-02/09/15, 03016-20/05/16, and 04917-19/07/17). The study also received support from the Embassy of France in the Republic of the Fiji Islands. The study was supported by the French Government’s 'Investissement d’Avenir' Program (Labex IBEID no. ANR-10-LABX-62-IBEID). C.L.L. was supported by an Australia National Health and Medical Research Council Fellowship (grant no. 1109035). A.J.K. was supported by a Wellcome Trust/Royal Society Sir Henry Dale Fellowship (grant no. 206250/Z/17/Z). The seroprevalence study was part of MSc research work by M.K. performed at the University of the South Pacific., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), Institut Pasteur [Paris]

    المصدر: Emerging Infectious Diseases
    Emerging Infectious Diseases, Vol 25, Iss 8, Pp 1535-1538 (2019)
    Emerging Infectious Diseases, 2019, 25 (8), pp.1535-1538. ⟨10.3201/eid2508.180524⟩
    Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2019, 25 (8), pp.1535-1538. ⟨10.3201/eid2508.180524⟩

    وصف الملف: application/pdf

  10. 10

    المصدر: Emerging Infectious Diseases
    Emerging Infectious Diseases, Vol 25, Iss 8, Pp 1485-1493 (2019)